Allergan plc (NYSE:AGN)

186.37
Delayed Data
As of Dec 06
 +0.29 / +0.16%
Today’s Change
114.27
Today|||52-Week Range
186.91
+39.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$61.2B

Company Description

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Contact Information

Allergan Plc
Clonshaugh Business & Tech. Park
Dublin Dublin D17 E400
P:3538622617000
Investor Relations:
(862) 261-7396

Employees

Shareholders

Other institutional61.34%
Mutual fund holders32.95%
Individual stakeholders0.31%

Top Executives

There are no executives to display.